VALFIX Medical Announces Issuance of Second U.S. Patent for Its Heart Valve Repair and Replacement Technology
By: VALFIX Medical Ltd.
VALFIX Medical is developing the first complete trans-catheter solution that combines repair and replacement treatments for Heart-Failure patients suffering from severe Mitral Regurgitation (MR); offering a viable alternative to open-heart surgery.
"We continue to protect, improve and advance our technology as planned. The issuance of this second patent continues to validate the uniqueness of our technology and its level of innovation,"
VALFIX Medical's technology is distinguished in its approach to offer both repair and replacement treatment in one procedure; emulating the "best-in-class"
VALFIX Medical continues to develop its patent portfolio with other patents in preparation and pending.
About VALFIX Medical:
VALFIX Medical is developing the first complete trans-catheter solution which, based on its multi-wire technology, combines repair and replacement treatments for the Mitral and the Tricuspid valves; offering a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at email@example.com
+972 73 374 4805
Page Updated Last on: Nov 06, 2019